Bruker Historical Balance Sheet
BRKR Stock | USD 57.95 0.43 0.74% |
Trend analysis of Bruker balance sheet accounts such as Total Stockholder Equity of 1.4 B, Non Current Assets Total of 2.2 B or Non Currrent Assets Other of 184.5 M provides information on Bruker's total assets, liabilities, and equity, which is the actual value of Bruker to its prevalent stockholders. By breaking down trends over time using Bruker balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Bruker latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bruker is a good buy for the upcoming year.
Bruker Inventory |
|
Bruker |
About Bruker Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Bruker at a specified time, usually calculated after every quarter, six months, or one year. Bruker Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bruker and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bruker currently owns. An asset can also be divided into two categories, current and non-current.
Bruker Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Bruker assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bruker books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Accounts Payable
An accounting item on the balance sheet that represents Bruker obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bruker are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Bruker's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Total Liabilities is relatively stable compared to the past year. As of 11/29/2024, Short and Long Term Debt Total is likely to grow to about 1.4 B, though Other Stockholder Equity is likely to grow to (906.6 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Stockholder Equity | 1.1B | 1.1B | 1.4B | 1.4B | Total Assets | 3.7B | 3.6B | 4.2B | 4.5B |
Bruker balance sheet Correlations
Click cells to compare fundamentals
Bruker Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bruker balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.8B | 3.0B | 3.7B | 3.6B | 4.2B | 4.5B | |
Total Stockholder Equity | 917.1M | 975.6M | 1.1B | 1.1B | 1.4B | 1.4B | |
Non Current Assets Total | 975.2M | 1.1B | 1.2B | 1.5B | 2.1B | 2.2B | |
Non Currrent Assets Other | 16.8M | 39.6M | 70.8M | (99.8M) | 175.7M | 184.5M | |
Other Assets | 77.3M | 180M | 160.9M | 208.9M | 240.2M | 252.2M | |
Common Stock Shares Outstanding | 156.6M | 154.6M | 152.9M | 149.4M | 147.2M | 143.8M | |
Liabilities And Stockholders Equity | 2.8B | 3.0B | 3.7B | 3.6B | 4.2B | 4.5B | |
Non Current Liabilities Total | 1.2B | 1.3B | 1.6B | 1.6B | 1.6B | 1.7B | |
Other Stockholder Equity | (333.8M) | (450.7M) | (582.5M) | (828.7M) | (954.3M) | (906.6M) | |
Total Liab | 1.9B | 2.1B | 2.6B | 2.5B | 2.8B | 3.0B | |
Short Long Term Debt Total | 860.3M | 891.5M | 1.3B | 1.2B | 1.4B | 1.4B | |
Other Current Liab | 388.8M | 210.1M | 234.4M | 596.8M | 316.2M | 237.4M | |
Total Current Liabilities | 645.6M | 793.6M | 938.5M | 913.8M | 1.2B | 1.3B | |
Property Plant And Equipment Net | 371.7M | 462.9M | 406.1M | 487M | 691.4M | 726.0M | |
Net Debt | 182M | 209.7M | 266M | 573.7M | 891.3M | 935.9M | |
Retained Earnings | 1.3B | 1.4B | 1.7B | 1.9B | 2.3B | 2.4B | |
Accounts Payable | 118.4M | 134.6M | 147.4M | 178.4M | 202.7M | 212.8M | |
Cash | 678.3M | 681.8M | 1.1B | 645.5M | 488.3M | 311.3M | |
Cash And Short Term Investments | 684.9M | 731.8M | 1.2B | 645.5M | 488.3M | 358.2M | |
Net Receivables | 362.2M | 335.3M | 416.9M | 595.3M | 621.8M | 652.9M | |
Inventory | 577.2M | 692.3M | 710.1M | 803.7M | 968.3M | 1.0B | |
Other Current Assets | 172M | 165.6M | 176.6M | 72.3M | 85.8M | 108.0M | |
Property Plant And Equipment Gross | 371.7M | 462.9M | 406.1M | 487M | 1.2B | 1.3B | |
Total Current Assets | 1.8B | 1.9B | 2.5B | 2.1B | 2.2B | 1.1B | |
Accumulated Other Comprehensive Income | (25.5M) | 3.7M | (8.2M) | 14.8M | 6M | 5.7M | |
Short Term Debt | 500K | 23.5M | 130.3M | 35.1M | 144.5M | 151.7M | |
Intangible Assets | 603.5M | 229.1M | 211.8M | 270.9M | 330.5M | 196.5M | |
Other Liab | 311M | 389.4M | 404.9M | 318.2M | 365.9M | 384.2M | |
Long Term Debt | 812.8M | 842.3M | 1.2B | 1.2B | 1.2B | 1.2B | |
Short Term Investments | 0.0 | 6.6M | 50M | 100M | 12M | 11.4M | |
Property Plant Equipment | 306.1M | 395.5M | 406.1M | 487M | 560.1M | 588.1M | |
Current Deferred Revenue | 137.9M | 189.2M | 197.5M | 225.7M | 400M | 420M | |
Treasury Stock | (543.8M) | (667M) | (820.3M) | (1.1B) | (976.5M) | (927.7M) | |
Good Will | 293M | 320.4M | 339.5M | 457.6M | 582.6M | 611.7M | |
Net Tangible Assets | 491.5M | 509.6M | 312.5M | 1.2B | 1.4B | 1.5B | |
Noncontrolling Interest In Consolidated Entity | 10.3M | 13.1M | 14.1M | 11.9M | 13.7M | 8.2M | |
Retained Earnings Total Equity | 1.3B | 1.4B | 1.7B | 1.9B | 2.2B | 2.3B | |
Long Term Debt Total | 812.8M | 842.3M | 1.2B | 1.2B | 1.4B | 1.4B |
Pair Trading with Bruker
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.Moving together with Bruker Stock
0.86 | A | Agilent Technologies Sell-off Trend | PairCorr |
0.88 | ME | 23Andme Holding Upward Rally | PairCorr |
0.64 | VALN | Valneva SE ADR | PairCorr |
Moving against Bruker Stock
0.78 | DRUG | Bright Minds Biosciences Trending | PairCorr |
0.61 | VANI | Vivani Medical | PairCorr |
0.58 | VCYT | Veracyte | PairCorr |
0.55 | VCEL | Vericel Corp Ord | PairCorr |
0.5 | VERA | Vera Therapeutics | PairCorr |
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.